91Ó°ÊÓ

Oncogenes are like the overzealous bosses of the cellular world. They are genes that, when mutated, become overactive and start pushing cells to divide excessively. This can lead to uncontrolled growth, one of the hallmarks of cancer. Normally, these genes play a regular role in normal cellular growth and division. However, when mutations occur, they can become too excited and promote cell growth at the wrong time or place. This is primarily why they are called "oncogenes," derived from "onco," meaning tumor or mass.

• Oncogenes promote unregulated cell division.
• They result from mutations in normal genes called proto-oncogenes.
• These mutations can arise from various factors like radiation or chemical exposure.

Addressing these overactive genes is crucial in cancer research and treatment. Gene therapy can attempt to introduce a normal copy of the oncogene to compete with the mutated version, potentially slowing down or stopping tumor growth.

Tumor-suppressor genes play the role of the cautious guardian in the cell. Their primary function is to keep cell growth and division in check and to prevent uncontrolled cellular proliferation. When these genes are normal, they help regulate the cell cycle and can trigger apoptosis if something goes awry (this is a programmed cell death process).

• They act as brake pedals for cell division.
• Mutations can make these genes inactive, leading to unchecked cell growth.
• Examples include famous genes like TP53 and RB1.

When tumor-suppressor genes get mutated, their "braking" function is compromised, leading to the risk of tumor formation. Gene therapy might be able to restore normal function by introducing a non-mutated version of the gene, thus reinstating its regulatory role.

Cancer treatment is a multifaceted approach to combat this complex disease. Traditional treatments include surgery to remove tumors, chemotherapy to kill cancer cells, and radiation therapy to target and destroy malignant tissues. However, these treatments can have significant side effects due to their lack of specificity for cancer cells alone.
Gene therapy emerges as a more targeted option. By focusing on the genes causing the cancer, it can offer more precise avenues for managing the disease. Here’s how it fits in:

• Gene therapy can introduce normal genes in place of mutated ones.
• It offers the potential to stop or slow down tumor growth more specifically.
• This approach seeks to reduce collateral damage to normal cells.

The goal is to reach a point where cancer can be treated like a chronic disease, with minimal impacts on life quality. While still in experimental stages, gene therapy represents a promising frontier.

Mutated genes are essentially errors in the genetic code that can lead to various consequences within cells. Normally, genes are blueprints for proteins which carry out essential functions. When mutations occur, they can alter protein function or regulation, sometimes leading to disease.

• Mutations can be inherited or acquired over a person's life.
• They can arise from environmental factors, such as UV light or chemicals.
• Not all mutations are harmful; some are neutral or even beneficial.

In the context of cancers, mutated genes can be particularly problematic when they involve proto-oncogenes or tumor-suppressor genes. These mutations can disrupt normal cellular functions, leading to cancerous growth. Understanding and correcting these mutations through methods like gene therapy could eventually revolutionize how we treat and think about cancer.